Total Payments
$12,445
2024 Payments
$351.90
Companies
20
Transactions
87
Medicare Patients
6,432
Medicare Billing
$882,948
Payment Breakdown by Category
Other$8,000 (64.3%)
Consulting$2,310 (18.6%)
Food & Beverage$1,850 (14.9%)
Travel$219.99 (1.8%)
Gifts$45.00 (0.4%)
Education$20.88 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,000 | 2 | 64.3% |
| Consulting Fee | $2,310 | 1 | 18.6% |
| Food and Beverage | $1,850 | 79 | 14.9% |
| Travel and Lodging | $219.99 | 1 | 1.8% |
| Gift | $45.00 | 1 | 0.4% |
| Education | $20.88 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $8,165 | 10 | $0 (2022) |
| Shire North American Group Inc | $2,554 | 3 | $0 (2019) |
| ABBVIE INC. | $417.20 | 25 | $0 (2024) |
| Horizon Therapeutics plc | $327.51 | 15 | $0 (2023) |
| Glaukos Corporation | $245.60 | 1 | $0 (2023) |
| Amgen Inc. | $158.10 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $139.93 | 6 | $0 (2023) |
| Alcon Vision LLC | $64.86 | 3 | $0 (2022) |
| Dompe US, Inc. | $56.69 | 2 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $54.23 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.90 | 15 | Amgen Inc. ($158.10) |
| 2023 | $786.17 | 28 | Horizon Therapeutics plc ($286.16) |
| 2022 | $318.63 | 19 | ABBVIE INC. ($174.68) |
| 2021 | $8,118 | 8 | Allergan, Inc. ($8,050) |
| 2020 | $94.55 | 4 | Allergan, Inc. ($94.55) |
| 2019 | $2,670 | 8 | Shire North American Group Inc ($2,530) |
| 2018 | $106.37 | 5 | Alcon Laboratories Inc ($32.05) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/01/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Ophthalmology | ||||||
| 07/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/03/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: EYE CARE | ||||||
| 05/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: EYE CARE | ||||||
| 03/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $39.73 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: EYE CARE | ||||||
| 02/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/29/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: SOLUTION/ DROPS | ||||||
| 01/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/27/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: TEPEZZA | ||||||
| 11/30/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: EYE CARE | ||||||
| 11/16/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $245.60 | General |
| 11/15/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: EYE CARE | ||||||
| 11/08/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: EYE CARE | ||||||
| 10/24/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: EYE CARE | ||||||
| 10/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: TEPEZZA | ||||||
| 10/10/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: TEPEZZA | ||||||
| 09/21/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: EYE CARE | ||||||
| 09/18/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,831 | 2,135 | $1.2M | $272,976 |
| 2022 | 17 | 1,675 | 1,944 | $941,874 | $231,701 |
| 2021 | 16 | 1,687 | 2,110 | $933,277 | $232,204 |
| 2020 | 12 | 1,239 | 1,485 | $590,210 | $146,067 |
Total Patients
6,432
Total Services
7,674
Medicare Billing
$882,948
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 110 | 192 | $401,856 | $87,950 | 21.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 670 | 802 | $293,532 | $74,713 | 25.5% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Office | 2023 | 37 | 37 | $91,000 | $22,448 | 24.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 184 | 184 | $79,488 | $20,337 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 221 | $56,797 | $14,665 | 25.8% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 51 | 51 | $44,520 | $12,513 | 28.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 26 | 37 | $35,557 | $9,636 | 27.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 151 | 206 | $59,946 | $6,627 | 11.1% |
| 67916 | Repair of turning-outward eyelid defect | Office | 2023 | 12 | 12 | $23,374 | $6,347 | 27.2% |
| 67908 | Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | Facility | 2023 | 11 | 11 | $22,120 | $4,311 | 19.5% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 104 | 108 | $25,920 | $3,765 | 14.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 62 | 63 | $16,821 | $2,766 | 16.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 95 | 102 | $13,770 | $2,713 | 19.7% |
| 68801 | Dilation of tear drainage opening | Office | 2023 | 19 | 20 | $9,177 | $1,646 | 17.9% |
| 92250 | Photography of the retina | Office | 2023 | 49 | 49 | $6,958 | $1,272 | 18.3% |
| 92134 | Imaging of retina | Office | 2023 | 39 | 40 | $5,400 | $1,267 | 23.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 575 | 706 | $258,396 | $66,370 | 25.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 76 | 125 | $261,625 | $58,433 | 22.3% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Office | 2022 | 32 | 32 | $101,500 | $23,185 | 22.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 160 | 160 | $63,855 | $17,635 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 198 | $44,588 | $13,631 | 30.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 34 | 47 | $40,964 | $11,700 | 28.6% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 32 | 32 | $17,658 | $7,473 | 42.3% |
| 67916 | Repair of turning-outward eyelid defect | Office | 2022 | 11 | 12 | $21,161 | $6,799 | 32.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 123 | 157 | $29,513 | $6,445 | 21.8% |
About Dr. John Lee, MD
Dr. John Lee, MD is a Ophthalmology healthcare provider based in Brookline, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124237326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lee, MD has received a total of $12,445 in payments from pharmaceutical and medical device companies, with $351.90 received in 2024. These payments were reported across 87 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,000).
As a Medicare-enrolled provider, Lee has provided services to 6,432 Medicare beneficiaries, totaling 7,674 services with total Medicare billing of $882,948. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Brookline, MA
- Active Since 05/22/2007
- Last Updated 07/08/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1124237326
Products in Payments
- DURYSTA (Drug) $547.98
- TEPEZZA (Drug) $327.51
- XIIDRA (Drug) $164.00
- TEPEZZA (Biological) $158.10
- XDEMVY (Drug) $54.23
- Iluvien (Drug) $41.19
- CyPass (Device) $32.05
- OXERVATE (Drug) $30.77
- AcrySof (Device) $29.20
- Oxervate (Drug) $25.92
- Syfovre (Drug) $25.00
- rocklatan (Drug) $24.60
- VYZULTA (Drug) $24.02
- TearCare (Device) $23.87
- Cequa (Drug) $22.98
- Rhopressa (Drug) $22.17
- ReSTOR (Device) $19.79
- Acuvue (Device) $18.42
- AcrySof IQ VIVITY (Device) $15.87
- V-GO (Device) $14.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brookline
Dr. Mark Hughes, Md, MD
Ophthalmology — Payments: $1.3M
Ophthalmology $1.3M
Dr. Jason Brenner, M.d, M.D
Ophthalmology — Payments: $24,654
Ophthalmology $24,654
Daniel Schwartz, Md, MD
Ophthalmology — Payments: $10,374
Ophthalmology $10,374
Dr. Samir Melki, M.d., Phd, M.D., PHD
Ophthalmology — Payments: $9,125
Ophthalmology $9,125
Dr. Jorge Arroyo, M.d., Mph, M.D., MPH
Ophthalmology — Payments: $5,628
Ophthalmology $5,628
Dr. Kevin Kaufmann, Md Phd, MD PHD
Ophthalmology — Payments: $5,512
Ophthalmology $5,512